Insulin and IGF-1 stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
We examined the interplay between the insulin/IGF-1- and beta-catenin-regulated pathways, both of which are suspected to play a role in hepatocarcinogenesis. Insulin and IGF-1 stimulated the transcription of a Lef/Tcf-dependent luciferase reporter gene by 3-4-fold in HepG2 cells. This stimulation was mediated through the activation of phosphatidylinositol 3-kinase (PI 3-K)/Akt and the inhibition of glycogen synthase kinase-3beta (GSK-3beta) since the effects of insulin and IGF-1 were inhibited by dominant-negative mutants of PI 3-K or Akt and an uninhibitable GSK-3beta. Together with inhibiting GSK-3beta, insulin and IGF-1 increased the cytoplasmic levels of beta-catenin. The PI 3-K/Akt/GSK-3beta pathway was not the sole to mediate insulin and IGF-1 stimulation of Lef/Tcf-dependent transcription. The Ras signalling pathway was also required as (i) the stimulatory effects of insulin and IGF-1 were inhibited by dominant-negative Ras or the MEK1 inhibitor PD98059 and (ii) activated Ha-Ras or constitutively active MEK1 synergized with catalytically inactive GSK-3beta to stimulate Lef/Tcf-dependent transcription. This study provides the first evidence that insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades bifurcating downstream of PI 3-K and involving GSK-3beta inhibition and Ras activation. These findings demonstrate for the first time the ability of insulin and IGF-1 to activate the beta-catenin pathway in hepatoma cells and thereby provide new insights into the role of these factors in hepatocarcinogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cross-talk between the Wnt and insulin signaling pathways has been demonstrated in different disorders such as diabetes and cancer49-53.”
From Altered proliferation and networks in neural cells derived from idiopathic autistic individuals (2017) · cites this paper as [52]
Citations
Cites
Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828
β-catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,529 · cited 2×
“Results are representative of three independent experiments Oncogene zation in Wnt/Wingless signalling (Aberle et al., 1997), we next wished to examine whether insulin- and IGF-1mediated GSK-3b inhibition a ected the level of bcatenin found in the cytoplasm of HepG2 cells.”
BackgroundA molecular mechanism for the effect of lithium on development.
Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,301 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundMECHANISMS OF WNT SIGNALING IN DEVELOPMENT
Wodarz, A., & Nusse, R. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.59 · Cited by 2,017 · cited 1×
“This pathway plays a critical role in development, proliferation and di erentiation (Wodarz and Nusse, 1998).”
BackgroundBinding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422 · cited 1×
“…molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted…”
BackgroundLithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321 · cited 1×
“Consistent with this, treatment with lithium chloride (LiCl), a pharmacological agent well-known for its inhibitory e ect on GSK-3b activity (Klein and Melton, 1996; Stambolic et al., 1996), increased reporter activity (Figure 3b).”
BackgroundFunctional Interaction of an Axin Homolog, Conductin, with β-Catenin, APC, and GSK3β
Behrens, J., Jerchow, B.-A., Würtele, M., Grimm, J., Asbrand, C., Wirtz, R., Kühl, M., Wedlich, D., & Birchmeier, W. (1998) · Science · doi:10.1126/science.280.5363.596 · Cited by 1,260 · cited 1×
“…coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system…”
BackgroundIkeda, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,246 · cited 1×
“…et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin is phosphorylated by GSK-3b (Ikeda et al., 1998) and targeted for degradation by the ubiquitin/ proteasome system (Aberle et al., 1997).”
BackgroundAssociation of the APC Gene Product with β-Catenin
Rubinfeld, B., Souza, B., Albert, I., Müller, O., Chamberlain, S. H., Masiarz, F. R., Munemitsu, S., & Polakis, P. (1993) · Science · doi:10.1126/science.8259518 · Cited by 1,223 · cited 1×
“…adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al., 1998). bcatenin…”
BackgroundAssociation of the APC Tumor Suppressor Protein with Catenins
Su, L.-K., Vogelstein, B., & Kinzler, K. W. (1993) · Science · doi:10.1126/science.8259519 · Cited by 1,188 · cited 2×
“…mainly at adherens junctions and any free b-catenin interacts with a high molecular mass complex including adenomatous polyposis coli (APC) (Su et al., 1993; Rubinfeld et al., 1993), glycogen synthase kinase-3b (GSK-3b) (Rubinfeld et al., 1996), and axin (Hart et al., 1998; Behrens et al.,…”
Background
Cited by
GSK3 takes centre stage more than 20 years after its discovery
FRAME, S., & COHEN, P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3590001 · Cited by 1,433
Decision making by p53: life, death and cancer
Oren, M. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,068
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.002 · Cited by 889
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity
Fang, D., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G. B., Kobayashi, R., Hunter, T., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 870
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 825
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Yoshida, T., & Delafontaine, P. (2020) · Cells · doi:10.3390/cells9091970 · Cited by 714
JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis
Steelman, L. S., Pohnert, S. C., Shelton, J. G., Franklin, R. A., Bertrand, F. E., & McCubrey, J. A. (2004) · Leukemia · doi:10.1038/sj.leu.2403241 · Cited by 684
Self-citationErk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
Ding, Q., Xia, W., Liu, J.-C., Yang, J.-Y., Lee, D.-F., Xia, J., Bartholomeusz, G., Li, Y., Pan, Y., Li, Z., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.009 · Cited by 597
Vosseller, K., Wells, L., Lane, M. D., & Hart, G. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072072399 · Cited by 485
Obesity and cancer risk: the role of the insulin-IGF axis
Renehan, A. G., Frystyk, J., & Flyvbjerg, A. (2006) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2006.08.006 · Cited by 480
Mills, R. J., Titmarsh, D. M., Koenig, X., Parker, B. L., Ryall, J. G., Quaife-Ryan, G. A., Voges, H. K., Hodson, M. P., Ferguson, C., Drowley, L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707316114 · Cited by 478
Altered proliferation and networks in neural cells derived from idiopathic autistic individuals
Marchetto, M. C., Belinson, H., Tian, Y., Freitas, B. C., Fu, C., Vadodaria, K. C., Beltrao-Braga, P. C., Trujillo, C. A., Mendes, A. P. D., Padmanabhan, K., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.95 · Cited by 466
Ding, Q., He, X., Hsu, J.-M., Xia, W., Chen, C.-T., Li, L.-Y., Lee, D.-F., Liu, J.-C., Zhong, Q., Wang, X., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00620-06 · Cited by 393
Zhang, K., Corsa, C. A., Ponik, S. M., Prior, J. L., Piwnica-Worms, D., Eliceiri, K. W., Keely, P. J., & Longmore, G. D. (2013) · Nature Cell Biology · doi:10.1038/ncb2743 · Cited by 393
Almeida, M., Han, L., Bellido, T., Manolagas, S. C., & Kousteni, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502168200 · Cited by 395
New therapies for hepatocellular carcinoma
Avila, M. A., Berasain, C., Sangro, B., & Prieto, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209550 · Cited by 383
“Activation of the IGFR has been shown to stimulate the Ras/Raf/MEK/ERK, PI3K/Akt/mTOR and b-catenin pathways in HCC cells, and is considered to participate in HCC development through an autocrine mechanism (Desbois-Mouthon et al., 2001; Alexia et al., 2004).”
BackgroundWNT/β-catenin signaling in the development of liver cancers
He, S., & Tang, S. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110851 · Cited by 351
Liu, Z., & Habener, J. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706105200 · Cited by 326
Obesity, Diabetes, and Increased Cancer Progression
Kim, D.-S., & Scherer, P. E. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2021.0077 · Cited by 302
Peroxisome-proliferator-activated receptor γ suppresses Wnt/β-catenin signalling during adipogenesis
MOLDES, M., ZUO, Y., MORRISON, R. F., SILVA, D., PARK, B.-H., LIU, J., & FARMER, S. R. (2003) · Biochemical Journal · doi:10.1042/bj20030426 · Cited by 307
Sharma, M., Chuang, W. W., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201919200 · Cited by 308
Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki, Y., Okamura, S., Hussain, S. P., Nagashima, M., He, P., Shiseki, M., Miura, K., & Harris, C. C. (2003) · PubMed · Cited by 323
Wu, Y., Ginther, C., Kim, J., Mosher, N., Chung, S., Slamon, D., & Vadgama, J. V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0155-t · Cited by 268
Minimization of exogenous signals in ES cell culture induces rostral hypothalamic differentiation
Wataya, T., Ando, S., Muguruma, K., Ikeda, H., Watanabe, K., Eiraku, M., Kawada, M., Takahashi, J., Hashimoto, N., & Sasai, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803078105 · Cited by 270
Interaction of FOXO with β-Catenin Inhibits β-Catenin/T Cell Factor Activity
Hoogeboom, D., Essers, M. A. G., Polderman, P. E., Voets, E., Smits, L. M. M., & Burgering, B. M. T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706638200 · Cited by 271
Ji, H., Wang, J., Nika, H., Hawke, D., Keezer, S., Ge, Q., Fang, B., Fang, X., Fang, D., Litchfield, D. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.034 · Cited by 270
“For instance, b-catenin-TCF/LEF-1 signaling can be activated by growth factors such as EGF, HGF, IGF-I, IGF-II, and insulin (Desbois-Mouthon et al., 2001; Lu et al., 2003; Morali et al., 2001; Müller et al., 2002).”
BackgroundPPAR and Oxidative Stress: Con() Catenating NRF2 and FOXO
Polvani, S., Tarocchi, M., & Galli, A. (2012) · PPAR Research · doi:10.1155/2012/641087 · Cited by 245
“To add further complexity to the system, other signaling pathways, such as the insulin and insulin-like growth factor 1 (IGF-1) pathways, activate βcatenin possibly through an AKT-dependent GSK3β phosphorylation [95, 96].”
BackgroundYang, K., Wang, X., Zhang, H., Wang, Z., Nan, G., Li, Y., Zhang, F., Mohammed, M. K., Haydon, R. C., Luu, H. H., et al. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.144 · Cited by 241
Vanamala, J., Reddivari, L., Radhakrishnan, S., & Tarver, C. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-238 · Cited by 242
Abnormalities of the APC/β-catenin pathway in endometrial cancer
Moreno-Bueno, G., Hardisson, D., Sánchez, C., Sarrió, D., Cassia, R., García-Rostán, G., Prat, J., Guo, M., Herman, J. G., Matías-Guiu, X., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205924 · Cited by 237
“…growth factor-1 the PI3K/Akt signal induces phosphorylation and inactivation of GSK3b, resulting in increased nuclear levels of b-catenin and stimulation of TCF-dependent transcription in liver Oncogene cancer (Desbois-Mouthon et al., 2001) as well as in melanoma (Satyamoorthy et al., 2001).”
BackgroundRole of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis
Xie, D., Gore, C., Liu, J., Pong, R.-C., Mason, R., Hao, G., Long, M., Kabbani, W., Yu, L., Zhang, H., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908133107 · Cited by 237
Wnt / β-Catenin Signaling Pathway as Novel Cancer Drug Targets
Luu, H., Zhang, R., Haydon, R., Rayburn, E., Kang, Q., Si, W., Park, J., Wang, H., Peng, Y., Jiang, W., et al. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043332709 · Cited by 231
“An increasing number of reports have indicated that β-catenin signaling may also be activated by Wnt-independent mechanisms in mammalian cells [65], including G-protein [66], integrin-linked kinase (ILK) [67], hepatocyte growth factor (HGF) [68,69], growth factor Gas6 [70], insulin-like growth factor-1 (IGF-1) [71,72]…”
BackgroundRegulation of Wnt/β-catenin signaling by posttranslational modifications
Gao, C., Xiao, G., & Hu, J. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-13 · Cited by 226
“Consistent with this result, overexpression of GSK3β-Ser9A (serine mutated to alanine) abolishes insulin and IGF-1 (Insulin-like growth factor-1)-induced activation of β-catenindependent transcription [155].”
BackgroundACLY facilitates colon cancer cell metastasis by CTNNB1
Wen, J., Min, X., Shen, M., Hua, Q., Han, Y., Zhao, L., Liu, L., Huang, G., Liu, J., & Zhao, X. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1391-9 · Cited by 232
Exon 3 mutations of CTNNB1 drive tumorigenesis: a review
Gao, C., Wang, Y., Broaddus, R., Sun, L., Xue, F., & Zhang, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23695 · Cited by 224
Wnt and beyond Wnt: Multiple mechanisms control the transcriptional property of β-catenin
Jin, T., George Fantus, I., & Sun, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.04.014 · Cited by 215
Song, S., Mazurek, N., Liu, C., Sun, Y., Ding, Q. Q., Liu, K., Hung, M.-C., & Bresalier, R. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4153 · Cited by 192
Alexia, C., Fallot, G., Lasfer, M., Schweizer-Groyer, G., & Groyer, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.029 · Cited by 191
Role of IGF1R in Breast Cancer Subtypes, Stemness, and Lineage Differentiation
Farabaugh, S. M., Boone, D. N., & Lee, A. V. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00059 · Cited by 182
Yang, M., Zhong, W. W., Srivastava, N., Slavin, A., Yang, J., Hoey, T., & An, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501535102 · Cited by 185
Epstein-Barr Virus Latent Membrane Protein 2A Activates β-Catenin Signaling in Epithelial Cells
Morrison, J. A., Klingelhutz, A. J., & Raab-Traub, N. (2003) · Journal of Virology · doi:10.1128/jvi.77.22.12276-12284.2003 · Cited by 185
Wnt signaling in intestinal inflammation
Moparthi, L., & Koch, S. (2019) · Differentiation · doi:10.1016/j.diff.2019.01.002 · Cited by 171
“Firstly, and perhaps most controversially, several studies suggested that growth factors induce Wnt/β-catenin pathway activation directly via AKT-dependent GSK3 inhibition (Desbois-Mouthon et al., 2001; Fukumoto et al., 2001; Sharma et al., 2002).”
BackgroundThe Wnt Signaling Pathway in Bipolar Disorder
Gould, T. D., & Manji, H. K. (2002) · The Neuroscientist · doi:10.1177/107385802237176 · Cited by 174
Xie, D., Yin, D., Tong, X., O’Kelly, J., Mori, A., Miller, C., Black, K., Gui, D., Said, J. W., & Koeffler, H. P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0666 · Cited by 172
Wnt signaling: relevance to β-cell biology and diabetes
Welters, H. J., & Kulkarni, R. N. (2008) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.08.004 · Cited by 167
Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators
Dubé, P. E., & Brubaker, P. L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00149.2007 · Cited by 166
Wnt signalling and the mechanistic basis of tumour development
Ilyas, M. (2005) · The Journal of Pathology · doi:10.1002/path.1692 · Cited by 170
WNT signaling in ovarian follicle biology and tumorigenesis
Boyer, A., Goff, A. K., & Boerboom, D. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.08.005 · Cited by 164
Smith, E., & Frenkel, B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m406294200 · Cited by 165
Dearth, R. K., Cui, X., Kim, H.-J., Kuiatse, I., Lawrence, N. A., Zhang, X., Divisova, J., Britton, O. L., Mohsin, S., Allred, D. C., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00260-06 · Cited by 165
Yi, F., Sun, J., Lim, G. E., Fantus, I. G., Brubaker, P. L., & Jin, T. (2008) · Endocrinology · doi:10.1210/en.2007-1142 · Cited by 157
Quarto, N., Wan, D. C., Kwan, M. D., Panetta, N. J., Li, S., & Longaker, M. T. (2010) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.091116 · Cited by 157
Wnt signalling and prostate cancer
Yardy, G., & Brewster, S. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500794 · Cited by 173
Shin, S.-Y., Rath, O., Zebisch, A., Choo, S.-M., Kolch, W., & Cho, K.-H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1377 · Cited by 147
Wnt/frizzled signaling in hepatocellular carcinoma
Lee, H. C., Kim, M., & Wands (2006) · Frontiers in bioscience · doi:10.2741/1933 · Cited by 164
Zonal gene expression in murine liver: Lessons from tumors
Hailfinger, S., Jaworski, M., Braeuning, A., Buchmann, A., & Schwarz, M. (2006) · Hepatology · doi:10.1002/hep.21082 · Cited by 142
Gherzi, R., Trabucchi, M., Ponassi, M., Ruggiero, T., Corte, G., Moroni, C., Chen, C.-Y., Khabar, K. S., Andersen, J. S., & Briata, P. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0050005 · Cited by 148
“Cross-talks between Wnt and PI3K-AKT signaling pathways have been described [24–27].”
BackgroundRetractedGSK3: A Kinase Balancing Promotion and Resolution of Inflammation
Hoffmeister, L., Diekmann, M., Brand, K., & Huber, R. (2020) · Cells · doi:10.3390/cells9040820 · Cited by 156
“Among the known growth factors, insulin-like growth factor 1 [99], platelet-derived growth factor BB [100], hepatocyte growth factor [101], fibroblast growth factor 2 [102], epidermal growth factor, and transforming growth factor (TGF-)β [103] as well as stem cell factor [104] have been demonstrated to inhibit GSK3 ac…”
BackgroundRochat, A., Fernandez, A., Vandromme, M., Molès, J.-P., Bouschet, T., Carnac, G., & Lamb, N. J. C. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-11-0816 · Cited by 146
“Some cases of cross talk between Wnt and insulin pathways have been reported (Fukumoto et al., 2001; Harwood, 2001), including on -catenin activity (Papkoff, 1997; Playford et al., 2000; Desbois-Mouthon et al., 2001).”
BackgroundThe Emerging Role of Insulin and Insulin-Like Growth Factor Signaling in Cancer Stem Cells
Malaguarnera, R., & Belfiore, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00010 · Cited by 143
Fischer, A. N. M., Fuchs, E., Mikula, M., Huber, H., Beug, H., & Mikulits, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210121 · Cited by 162
“…involving PDGF is the activation of the PI3K–Akt pathway resulting in the inhibition of glycogen synthase kinase 3b (GSK-3b) and allowing b-catenin to translocate to the nucleus in order to activate T-cell factor/lymphoid enhancing factor-dependent transcription (Desbois-Mouthon et al., 2001).”
BackgroundBaryawno, N., Sveinbjörnsson, B., Eksborg, S., Chen, C.-S., Kogner, P., & Johnsen, J. I. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-0578 · Cited by 138
Tran, T. T., Naigamwalla, D. Z., Oprescu, A. I., Lam, L., McKeown‐Eyssen, G., Bruce, W. R., & Giacca, A. (2006) · Endocrinology · doi:10.1210/en.2005-1012 · Cited by 148
The Multifaceted Roles of Proline in Cell Behavior
Patriarca, E. J., Cermola, F., D’Aniello, C., Fico, A., Guardiola, O., Cesare, D. D., & Minchiotti, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728576 · Cited by 153
Bonnette, S. G., & Hadsell, D. L. (2001) · Endocrinology · doi:10.1210/endo.142.11.8500 · Cited by 149
“In this respect, analysis of the phosphorylation state of proteins involved in cell survival, such as Akt (14), or proteins involved in proliferation, such as MAPK (16) or -catenin (17, 18), would be valuable.”
BackgroundShimizu, M., Shirakami, Y., Sakai, H., Tatebe, H., Nakagawa, T., Hara, Y., Weinstein, I. B., & Moriwaki, H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2007.11.026 · Cited by 135
Frago, L. M., Pañeda, C., Dickson, S. L., Hewson, A. K., Argente, J., & Chowen, J. A. (2002) · Endocrinology · doi:10.1210/en.2002-220261 · Cited by 126
Fibroblast Growth Factor-2 Induces Lef/Tcf-dependent Transcription in Human Endothelial Cells
Holnthoner, W., Pillinger, M., Gröger, M., Wolff, K., Ashton, A. W., Albanese, C., Neumeister, P., Pestell, R. G., & Petzelbauer, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209354200 · Cited by 131
Sunters, A., Armstrong, V. J., Zaman, G., Kypta, R. M., Kawano, Y., Lanyon, L. E., & Price, J. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027086 · Cited by 122
Liu, J., Ding, X., Tang, J., Cao, Y., Hu, P., Zhou, F., Shan, X., Cai, X., Chen, Q., Ling, N., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027496 · Cited by 127
“Many growth factors, including IGF-1, EGF and HGF have been implicated in GSK3b inhibition [39–41].”
BackgroundLi, H., Batth, I. S., Qu, X., Xu, L., Song, N., Wang, R., & Liu, Y. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0576-5 · Cited by 135
Kamemura, K., & Hart, G. W. (2003) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(03)01004-3 · Cited by 128
Acromegaly, growth hormone and cancer risk
Renehan, A. G., & Brennan, B. M. D. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.08.011 · Cited by 125
van der Velden, J. L. J., LANGEN, R. C. J., KELDERS, M. C. J. M., Wouters, E. F. �., Janssen-Heininger, Y. M. W., & Schols, A. M. W. J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00068.2005 · Cited by 122
The signaling landscape of insulin-like growth factor 1
Khan, M. Z., Zugaza, J. L., & Torres‐Alemán, I. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.108047 · Cited by 132
β-Catenin Signaling in Fibroproliferative Disease
Bowley, E., O’Gorman, D. B., & Gan, B. S. (2006) · Journal of Surgical Research · doi:10.1016/j.jss.2006.07.026 · Cited by 120
Oncogenic K-ras Stimulates Wnt Signaling in Colon Cancer Through Inhibition of GSK-3β
Li, J., Mizukami, Y., Zhang, X., Jo, W., & Chung, D. C. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.067 · Cited by 125
Insulin and the Lung: Connecting Asthma and Metabolic Syndrome
Singh, S., Prakash, Y. S., Linneberg, A. R., & Agrawal, A. (2013) · Journal of Allergy · doi:10.1155/2013/627384 · Cited by 117
Aberrant regulation of Wnt signaling in hepatocellular carcinoma
Liu, L., Xie, S., Chen, Y.-T., Xue, J.-L., Zhang, C., & Zhu, F. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i33.7486 · Cited by 109
Molecular determinants of Akt-induced keratinocyte transformation
Segrelles, C., Moral, M., Lara, M. F., Ruiz, S., Santos, M., Leis, H., García‐Escudero, R., Martínez‐Cruz, A. B., Martínez‐Palacio, J., Hernández, P., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209155 · Cited by 109
“…activation of the Wnt signaling pathway mediated by Akt It has been reported that Akt may interfere with elements of the Wnt pathway leading to increased expression and activity of Wnt effectors (Delcommenne et al., 1998; D’Amico et al., 2000; Desbois-Mouthon et al., 2001; Gotoh et al., 2003).”
BackgroundCross-talk between Insulin and Wnt Signaling in Preadipocytes
Palsgaard, J., Emanuelli, B., Winnay, J. N., Sumara, G., Karsenty, G., & Kahn, C. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337048 · Cited by 98
“-Catenin has also been shown to accumulate in response to insulin in intestinal L cells (22, 33), and both insulin and insulin-like growth factor 1 (IGF-1) stimulation activate the -catenin signaling pathway in hepatoma cells (34).”
BackgroundChen, J., Wu, A., Sun, H., Drakas, R. A., Garofalo, C., Cascio, S., Surmacz, E., & Baserga, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504516200 · Cited by 114
Park, C.-Y., Choi, S.-H., Kang, S., Kang, J.-I., Ahn, B. Y., Kim, H., Jung, G., Choi, K. Y., & Hwang, S. B. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.026 · Cited by 104
“b-Catenin-TCF/LEF-1 signaling can be activated by growth factors, such as epidermal growth factor (EGF), hepatocyte growth factor, insulin-like growth factor I, insulin-like growth factor II, and insulin [35–38].”
BackgroundKolegraff, K. N., Nava, P., Helms, M. N., Parkos, C. A., & Nusrat, A. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-10-0845 · Cited by 104
“…Ser-9 residue of GSK-3β, which has been proposed to enhance β-catenin signaling by promoting the accumulation of β-catenin protein levels, in a manner analogous to Wnt-mediated GSK-3β inactivation (Desbois-Mouthon et al., 2001; Sharma et al., 2002; Naito et al., 2005; Mulholland et al., 2006).”
BackgroundOverexpression of Insulin Receptor Substrate-2 in Human and Murine Hepatocellular Carcinoma
Boissan, M., Beurel, E., Wendum, D., Rey, C., Lécluse, Y., Housset, C., Lacombe, M., & Desbois‐Mouthon, C. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62058-5 · Cited by 100
Self-citationMolecular targeted therapy for hepatocellular carcinoma: Current and future
Shin, J. W. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i37.6144 · Cited by 91
Caveolin-1–LRP6 Signaling Module Stimulates Aerobic Glycolysis in Prostate Cancer
Tahir, S. A., Yang, G., Goltsov, A. A., Song, K., Ren, C., Wang, J., Chang, W., & Thompson, T. C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3040 · Cited by 95
Laguë, M.-N., Paquet, M., Fan, H.-Y., Kaartinen, M. J., Chu, S., Jamin, S. P., Behringer, R. R., Fuller, P. J., Mitchell, A., Doré, M., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn186 · Cited by 88
Castellone, M. D., Falco, V. D., Rao, D. M., Bellelli, R., Muthu, M., Basolo, F., Fusco, A., Gutkind, J. S., & Santoro, M. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1982 · Cited by 108
Chen, M. J., & Russo-Neustadt, A. A. (2007) · Growth Factors · doi:10.1080/08977190701602329 · Cited by 86
“Such G-protein activation can also result from IGF-1 receptor activation, eventually culminating in Rasdependent ERK signaling (Desbois-Mouthon et al. 2001).”
BackgroundDubé, P. E., Rowland, K., & Brubaker, P. L. (2007) · Endocrinology · doi:10.1210/en.2007-0561 · Cited by 100
Mauro, L., Salerno, M., Morelli, C., Boterberg, T., Bracke, M., & Surmacz, E. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10207 · Cited by 94
PIK3CA and APC mutations are synergistic in the development of intestinal cancers
Deming, D. A., Leystra, A. A., Nettekoven, L., Sievers, C., Miller, D., Middlebrooks, M., Clipson, L., Albrecht, D., Bacher, J., Washington, M. K., et al. (2014) · Oncogene · doi:10.1038/onc.2013.167 · Cited by 78
The growth hormone–insulin-like growth factor-I axis and colorectal cancer
Bustin, S. A., & Jenkins, P. J. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02104-9 · Cited by 83
Akhtar, A., Dhaliwal, J., Saroj, P., Uniyal, A., Bishnoi, M., & Sah, S. P. (2020) · Inflammopharmacology · doi:10.1007/s10787-019-00681-7 · Cited by 84
Evidence for a link between IGF-I and cancer
Jenkins, P., & Bustin, S. A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.151s017 · Cited by 82
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
Vella, V., Nicolosi, M. L., Giuliano, S., Bellomo, M., Belfiore, A., & Malaguarnera, R. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00031 · Cited by 93
Dysregulation of glycogen synthase kinase-3β signaling in hepatocellular carcinoma cells
Desbois‐Mouthon, C., Eggelpoël, M.-J. B.-V., Beurel, E., Boissan, M., Delélo, R., Cadoret, A., & Capeau, J. (2002) · Hepatology · doi:10.1053/jhep.2002.37192 · Cited by 82
Self-citationMaternal Huluwa dictates the embryonic body axis through β-catenin in vertebrates
Yan, L., Chen, J., Zhu, X., Sun, J., Wu, X., Shen, W., Zhang, W., Tao, Q., & Meng, A. (2018) · Science · doi:10.1126/science.aat1045 · Cited by 90
Gotoh, J., Obata, M., Yoshie, M., Kasai, S., & Ogawa, K. (2003) · Carcinogenesis · doi:10.1093/carcin/24.3.435 · Cited by 85
Metadata
- Authors
- Desbois-Mouthon, C., Cadoret, A., Blivet-Van Eggelpoël, M.-J., Bertrand, F., Cherqui, G., Perret, C., & Capeau, J.
- Affiliations
- Inserm (FR)
- Venue
- Oncogene
- Published
- 2001-01-11
- Volume
- 20
- Issue
- 2
- Pages
- 252-259
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2069349104
- Cited by
- 321
- References
- 51
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 10 · 2022: 8 · 2021: 11 · 2020: 15 · 2019: 14 · 2018: 11 · 2017: 12 · 2016: 5 · 2015: 11 · 2014: 13 · 2013: 25 · 2012: 16
- FWCI
- 4.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- insulin, insulin-like growth factor I, β-catenin signaling, GSK-3β inhibition, Ras signaling, PI3K/Akt signaling, MEK1, hepatocarcinogenesis, hepatoma cells, signal transduction
- MeSH terms
- Cell Division, Cytoskeletal Proteins, DNA-Binding Proteins, Enzyme Activation, Enzyme Inhibitors, Flavonoids, Carcinoma, Hepatocellular, Humans, Insulin, Insulin-Like Growth Factor I, Mutation, Proto-Oncogene Proteins, Genes, ras, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Signal Transduction, Trans-Activators, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Genes, Reporter, Phosphatidylinositol 3-Kinases, Mitogen-Activated Protein Kinase Kinases, Glycogen Synthase Kinases, Glycogen Synthase Kinase 3, MAP Kinase Kinase 1, Proto-Oncogene Proteins c-akt, beta Catenin, Lymphoid Enhancer-Binding Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.